Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.40 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.36 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.36 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3995849 | 0.86 | TBXAS1 (0.37) | ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A | |
| SCHEMBL7374428 | 0.84 | LMNA (0.44) | ALDH1A1SMN1; SMN2NPC1CYP3A4TSHR | |
| SCHEMBL384128 | 0.83 | ALDH1A1 (0.37) | ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A | |
| SCHEMBL9181515 | 0.82 | XDH (0.43) | ALDH1A1SMN1; SMN2NPC1RAB9ACYP3A4 | |
| SCHEMBL11334976 | 0.80 | ALDH1A1 (0.44) | ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A | |
| SCHEMBL6048435 | 0.79 | SMN1; SMN2 (0.37) | ALDH1A1NUDT1KDM4ESMN1; SMN2NPC1 | |
| SCHEMBL11111898 | 0.77 | TSHR (0.58) | ALDH1A1NUDT1CYP3A4HSD17B10KMT2A | |
| SCHEMBL15528122 | 0.77 | TXN (0.37) | ALDH1A1NUDT1KDM4ESMN1; SMN2NPC1 | |
| SCHEMBL11294381 | 0.77 | ALDH1A1 (0.36) | ALDH1A1NUDT1KDM4ESMN1; SMN2NPC1 | |
| SCHEMBL4868770 | 0.76 | KMT2A (0.49) | ALDH1A1NUDT1KDM4ENPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150280266-A1 | BIOFUEL CELL, METHOD FOR PRODUCTION OF BIOFUEL CELL, ELECTRONIC DEVICE, ENZYME IMMOBILIZATION ELECTRODE, METHOD FOR PRODUCTION OF ENZYME IMMOBILIZATION ELECTRODE, ELECTRODE FOR PRODUCTION OF ENZYME IMMOBILIZATION ELECTRODE, METHOD FOR 5 PRODUCTION OF ELECTRODE FOR PRODUCTION OF ENZYME IMMOBILIZATION ELECTRODE AND ENZYME REACTION USING DEVICE | TOHOKU MURATA MANUFACTURING CO., LTD. (JP) | 2015-10-01 | — | — | US | disclosed |
| EP-2176264-B1 | IMIDAZO-, PYRAZOLOPYRAZINES AND IMIDAZOTRIAZINES FOR TREATING HEMATOLOGICAL DISORDERS | BAYER IP GMBH (DE) | 2012-12-19 | — | — | EP | disclosed |
| EP-1732901-B1 | ANTIVIRAL 4-AMINOCARBONYLAMINO-SUBSTITUTED IMIDAZOLE COMPOUND | AICURIS GMBH & CO KG (DE) | 2011-11-02 | — | — | EP | disclosed |
| EP-2176264-A1 | IMIDAZO-, PYRAZOLOPYRAZINES AND IMIDAZOTRIAZINES AND THEIR USE | Bayer Schering Pharma AG (DE) | 2010-04-21 | — | — | EP | disclosed |
| EP-1853582-B1 | HETEROCYCLYLAMIDE-SUBSTITUTED IMIDAZOLES | AICURIS GMBH & CO KG (DE) | 2009-10-21 | — | — | EP | disclosed |
| WO-2009007029-A1 | IMIDAZO-, PYRAZOLOPYRAZINES AND IMIDAZOTRIAZINES AND THEIR USE | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2009-01-15 | — | — | WO | disclosed |
| EP-1853582-A2 | HETEROCYCLYLAMIDE-SUBSTITUTED IMIDAZOLES | AiCuris GmbH & Co. KG (DE) | 2007-11-14 | — | — | EP | disclosed |
| EP-1732901-A1 | ANTIVIRAL 4-AMINOCARBONYLAMINO-SUBSTITUTED IMIDAZOLE COMPOUND | Bayer HealthCare AG (DE) | 2006-12-20 | — | — | EP | disclosed |
| WO-2006089664-A2 | HETEROCYCLYLAMIDE-SUBSTITUTED IMIDAZOLES | AICURIS GMBH & CO. KG (DE) | 2006-08-31 | — | — | WO | disclosed |
| WO-2005092865-A1 | ANTIVIRAL 4-AMINOCARBONYLAMINO-SUBSTITUTED IMIDAZOLE COMPOUND | BAYER HEALTHCARE AG (DE) | 2005-10-06 | — | — | WO | disclosed |